View in EDS HTML Full Text PDF Full Text

Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Authors: Dequin, Pierre-François1,2,3, Heming, Nicholas4,5, Meziani, Ferhat6,7, Plantefève, Gaëtan8, Voiriot, Guillaume9,10, Badié, Julio11, François, Bruno12,13,14, Aubron, Cécile15,16, Ricard, Jean-Damien17, Ehrmann, Stephan1,2,3, Jouan, Youenn1,2,3, Guillon, Antoine1,2,3, Leclerc, Marie18, Coffre, Carine18, Bourgoin, Hélène19, Lengellé, Céline20, Caille-Fénérol, Caroline14, Tavernier, Elsa3, Zohar, Sarah21, Giraudeau, Bruno3,22
Source: JAMA: Journal of the American Medical Association. 10/6/2020, Vol. 324 Issue 13, p1298-1306. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00987484
DOI:10.1001/jama.2020.16761